Tiziana Life Sciences (TLSA) to Present BANYAN Phase 2a Poster at ALS Nexus

TLSA Tiziana Life Sciences Ltd

$0.67 -2.86%

View chart & analysis →

LGPS +5.50%

1. 1Tiziana Life Sciences (TLSA) will present a poster on the Phase 2a BANYAN trial of intranasal foralumab at ALS Nexus 2026
2. 2In an Orlando Monday poster session, Dr. Pinar Uysal will cover preclinical data, trial design, and MyMatch screening
3. 3BANYAN is a 3-to-1 randomized, placebo-controlled, multicenter trial now in the initiation phase

Source Proactive +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →